Designing adequate instruments for testing mental functions is a task of the utmost importance in the field of clinical research on dementia. In 1983, Katzman et al' described the Short Orientation Memory Concentration Test (OMCT), a six item version of Blessed's Mental Status Test,2 both of which had been found to correlate well with pathological findings in the brain of demented patients. The advantage of the OMCT is its brevity and high face validity. To our knowledge, there are no published sensitivity or specificity standards for this test. In order to know if the OMCT is more specific or sensitive than other widely used mental status tests, we studied comparatively the OMCT, the Mental Status Questionnaire (MSQ)3 and the Mini Mental State Examination (MMSE)4 in a population of demented and non demented patients. In the group of demented patients concurrent validity and test-retest reliability of the OMCT were evaluated in patients affected by senile dementia of Alzheimer type (SDAT).
Patients and methods
The subjects were 133 patients referred to the department of Neurology. They ranged in age from 37 to 94 years. There were 58 males and 75 females, subdivided in four subgroups according to their diagnostic category. The controls were 23 subjects (8 male, 15 female, mean age 759 years, range 50-91) living in the community and referred for functional disorders. They were free of psychotropic or antidepressant drugs. There was no evidence of stroke or other CNS disease from history and detailed neurological examination.
The neurological sample were 33 subjects (17 male, 16 female, mean age 64 5 years, range 37-91) with diagnosis established in the department of Neurology.
Diagnoses included Parkinson's disease without cognitive impairment (9), transient ischaemic attacks (7), transient global amnesia (3), traumatic sequellae (3), transient cerebral anoxia after cardiac arrest (3), epilepsy (2), other neurological diseases (6) . The patients were treated according to their clinical condition but free of neuroleptics or antidepressant drugs. The psychiatric sample were 33 subjects (15 male, 18 female, mean age 56 5 years, range 30-77) referred from psychiatric departments in our hospital or outside. Clinical diagnoses were established by experienced psychiatrists according to the DSM III criteria.5 They were major depressive disorder (11) , schizophrenia (9) , other psychotic disorders (2), personality disorder due to alcohol abuse (7) , delirium (2) , neurotic disorders (1), no DSM III condition (1) . All The mean scores for each test in each diagnostic category are indicated in table 1 . The OMCT was highly correlated with the MSQ and MMSE scores (respectively r = -0-896. p < 0-001 and r = -0-926, p < 0.001). One way analysis of variance (ANOVA) across the four groups of patients for each of the three tests showed significant differences (F = 58 9 df = 3, 129 p < 0-001, F = 89 4 p < 0-001, F93 9 p < 0-001 for MSQ, MMSE and OMCT, respectively). The OMCT discriminated among demented and normal subjects, as did the MMSE and MSQ. Among the three tests, the OMCT was the only one to discriminate significantly psychiatric from neurological patients for mild cognitive impairment (t = 2 50, According to the defined cut-off points, false positive results were slightly more frequent with OMCT (11%) than with MSQ and MMSE (5%). We subsequently calculated sensitivity and specificity (table  4) for the different values of the OMCT, MSQ and MMSE scores. It is shown that a higher range of sensitivity of the OMCT is obtained for a score lower than 8 but that specificity is lower (82%) for such a cut-off score. The comparison of the curves shows that the best ratio of sensitivity/specificity is obtained at the cut-off score 10/11. This is equivalent to a cutoff score of 22/23 on the MMSE in our sample. When the OMCT score was given twice 1 month apart in 18 clinically stable SDAT patients by the same tester, the correlation was highly significant (Pearson r = 0-829, df = 16, p < 0 001). Wilcoxon T was not significant (N = 12, T = 28) and the practice effect was nil.
A 6 to 21 months follow-up was available in nine SDAT patients. The OMCT was given serially every 2 or 3 months and the scores appeared stable. (table 6) . No significant difference was found between the first and the last evaluations compared by a Wilcoxon matched pairs signed rank test (N = 6, T = 9).
Discussion
As predicted by Katzman et al,' patients clinically classified as having no cognitive impairment scored 10 or less on OMCT in the control and neurological groups, irrespective of their age. Nevertheless, the patients older than 80 scored significantly less than the younger patients. Comparatively, the MMSE and MSQ scores were respectively 24 or more and 9 or more. These results are similar to those obtained in the literature using the MMSE in elderly retired residents49 and in neurological patients. 10 In the group of demented patients, 39/42 (92%) scored or more on the OMCT and 22 or less on the MMSE. It is noticeable that the two patients with frontal dementia had normal scores on the three tests, suggesting that the OMCT is not useful in screening for this type of dementia. These two patients fit the DSM III criteria for dementia since they had a loss of intellectual abilities which interfered with social functioning, impaired judgment and personality change. The patient with progressive supranuclear palsy showed disorders of language and graphic perseverations. Both patients showed a decrease in overall intellectual functioning with impaired verbal and performance WAIS subtests, impaired Benton's visual retention test form C (PSP patient, university professor: VIQ = 104, PIQ = 98, Benton 4/7. Pick patient, technician: VIQ = 97, PIQ = 88, Benton 5/6). Both had a significant frontal atrophy on CT scan. Both have been followed serially during more Table 6 Individual OMCT scores in 9 SDAT patients during a 6 to 21 months follow-up I  67F  28  25  28  28  2  68M  28  28  28  28  28  28  3  65M  20  20  18  20  24  25  20  22  25  4  72M  21  18  18  22  5  65M  28  25  28  28  6  69F  25  23  25  28  7  58F  14  16 24  26  22  8  67M  12  10  13 8  10  9  77M  19  14  17   1  3  5  7  9  11  1 The test-retest reliability by a single examiner showed a high correlation at 1 month interval and no difference between the two evaluations using the Wilcoxon matched pairs signed rank test. Nevertheless, in relation to the weighted score of the OMCT, it is likely that the reliability by different observers is lower than with the MMSE or MSQ. When clinically stable patients were studied serially over 6 to 21 months, the scores appeared stable. Nevertheless, the group is too small for statistical analysis and three patients scored the maximum range at the beginning of evaluation.
We could not test the usefulness of the OMCT in distinguishing between organic dementia and pseudodementia of depression since no patient was referred with the latter condition. It is likely that the OMCT is not specific in this respect.
In conclusion, while OMCT is not of aetiological value, it is useful in screening for dementia. It appears highly sensitive and specific at levels similar to the MMSE. Its value in identifying mild cognitive impairment in psychiatric patients and dementia at the onset is probably worth emphasising. Further studies are required to know if the test is specific for distinction between true dementia and pseudo-dementia of depression. 
